## DRI: Darden Restaurants, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -1.1% below STRENGTH zone (3.0-6.0%); PEG 1.87 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-8.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($177.73)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Jim Cramer Says Darden (DRI)’s Olive Garden is the OG**
- Source: Insider Monkey | 20251222T122720 | Neutral | Relevance: 100%
- Jim Cramer recently discussed Darden Restaurants, Inc. (NYSE:DRI), highlighting Olive Garden as the "OG." The company reported its second fiscal quarter earnings with $3.1 billion in revenue, beating analyst estimates, but its adjusted EPS of $2.08 missed expectations. Cramer noted the role of chicken in Darden's performance, especially for Olive Garden, in context of fluctuating meat prices.

**2. Patton Fund Management Inc. Lowers Stake in Darden Restaurants, Inc. $DRI**
- Source: MarketBeat | 20251223T124201 | Neutral | Relevance: 100%
- Patton Fund Management Inc. significantly reduced its stake in Darden Restaurants by 86% in the third quarter of 2025, selling 8,775 shares and retaining 1,423 shares valued at approximately $271,000. Despite this, Darden Restaurants maintains a "Moderate Buy" consensus rating from analysts with an average price target of $223.75, and the company recently declared a quarterly dividend of $1.50 with a 3.2% yield. Other institutional investors, such as Marshall Wace LLP and Invesco Ltd., have notably increased their positions in the restaurant operator.

**3. Darden Restaurants Q2 Earnings Call Highlights**
- Source: MarketBeat | 20251223T020842 | Bullish | Relevance: 100%
- Darden Restaurants reported strong Q2 fiscal 2026 results with total sales up 7% year-over-year and same-restaurant sales increasing by 4.3%, exceeding industry benchmarks. Despite higher-than-anticipated commodity inflation, particularly in beef, the company's various brands like Olive Garden and LongHorn Steakhouse showed solid performance. Darden also updated its fiscal 2026 guidance, projecting increased total sales and adjusted diluted EPS, even as it continues to prioritize value for guests over aggressive pricing.

**4. Darden Restaurants (NYSE:DRI) Stock Price Expected to Rise, Mizuho Analyst Says**
- Source: MarketBeat | 20251222T180448 | Somewhat-Bullish | Relevance: 100%
- Mizuho has increased its target price for Darden Restaurants (NYSE:DRI) from $185 to $195, while maintaining a "neutral" rating, predicting a potential upside of 2.79% from its current price. Despite missing EPS estimates slightly in the last quarter, Darden reported strong revenue growth and provided optimistic FY2026 guidance. The stock is currently rated a "Moderate Buy" by analysts, with a consensus target price of $223.75, amid significant institutional ownership and recent insider stock sales.

**5. Jim Cramer Says Darden (DRI)’s Olive Garden is the OG**
- Source: Yahoo Finance | 20251222T071900 | Neutral | Relevance: 100%
- Jim Cramer recently discussed Darden Restaurants, Inc. (DRI), highlighting its Olive Garden brand. Darden reported strong Q2 fiscal earnings with $3.1 billion in revenue, beating analyst estimates, though adjusted earnings per share slightly missed. Analysts reiterated ratings, with some noting weaker trends at Olive Garden but stable performance at LongHorn Steakhouse despite volatile beef prices impacting margins.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 7)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Mizuho | $195 | $185 | +5% |
| 2025-12-19 | Stephens & Co. | $205 | $205 | 0% |
| 2025-12-19 | BTIG | $225 | $225 | 0% |
| 2025-12-17 | Guggenheim | $230 | $235 | -2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Mizuho | main | Neutral |
| 2025-12-19 | Stephens & Co. | reit | Equal-Weight |
| 2025-12-19 | BTIG | reit | Buy |
| 2025-12-17 | Guggenheim | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.00M) |
| Sells | 4 ($0.31M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 57.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Capital World Invest: 12.8% (+1.6%)
- Vanguard Group Inc: 12.0% (-0.2%)
- Blackrock Inc.: 8.5% (+5.8%)
- JPMORGAN CHASE & CO: 4.6% (+256.8%)
- State Street Corpora: 4.2% (-0.3%)

### Key Risks

1. Long-term trend broken: trading 5.8% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.87 elevated, pricing in significant growth expectations. Forward P/E 16.4x stretched relative to 8% growth. Quality metrics strong (ROE 54%). Analyst sentiment negative (7 target cuts vs 1 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $21.8B |
| Beta | 0.66 |
| 52W Range | $169.00 - $228.27 |
| Short Interest | 4.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.87 |
| Forward P/E | 16.4 |
| Current P/E | 17.7 |
| YoY Growth | 7.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 7.3% to -1.1% (-8.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.1pp (needs >3.0% for momentum thesis). Below SMA200 (0.94x), long-term trend not supportive. MACD histogram positive (1.13), confirming momentum. RSI neutral at 57. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.06% (CS: 49) | Neutral |
| RSI_14 | 57.2 | Neutral |
| MACD Histogram | 1.13 | Bullish |
| vs SMA20 | 1.027x | Above |
| vs SMA50 | 1.036x | Above |
| vs SMA200 | 0.942x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $186.99
- **Stop Loss:** $177.73 (5.0% risk)
- **Target:** $196.25 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 97
- **Position Value:** $18,138.03
- **Portfolio %:** 18.14%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.10 | $2.08 | -0.8% |
| 2025Q3 | $2.01 | $1.97 | -2.0% |
| 2025Q2 | $2.97 | $2.98 | +0.4% |
| 2025Q1 | $2.80 | $2.80 | +0.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*